Reinventing disinfection to safely and continuously kill germs, mold, and fungi with the flip of a light switch through advanced LED technology.

Hospital-acquired infections are the number one patient killer in the U.S. According to the CDC, 1 in 25 patients contract infections from hospital stays. This burden is expensive, costing the U.S. health-care system an estimated $30 billion a year. These diseases are dangerous and preventable, and Vital Vio has a next generation solution. The health-care company has reinvented disinfection, providing facilities managers and homeowners new tools to continuously kill germs indoors with the flip of a light switch. The company's VioSafe® White Light Disinfection® technology is suitable for continuous human exposure. Used in combination with traditional intermittent cleaning in hospitals, homes, public spaces, and workplaces, Vital Vio's technology multi-tasks to safely, effectively, and continuously kill bacteria and other harmful organisms on indoor surfaces, while also illuminating the room. Vital Vio has been awarded several U.S. Patents for its innovative technologies and products, with numerous more patents pending. Clinical studies and independent research have shown that the VioSafe® technology protects against MRSA, E. coli, Salmonella, Listeria, and mold/mildew. This germ-killing technology is now in use around the world.


Health Water and Sanitation Infrastructure Life on Land Sustainable Cities

Troy, New York, United States


Colleen Costello

Colleen Costello (CEO & Co-Founder at Vital Vio) has been an Unreasonable Fellow since October 2018 after participating in Unreasonable Impact Americas 2018.

Unreasonable Impact Americas 2018

Connect with Vital Vio

Follow Vital Vio on social media below.

  • Featured VentureElvis & Kresse

  • Featured VentureAngaza